GlobalDeal

Solid Biosciences

Biotechnology · Boston, United States

solidbio.com

About Solid Biosciences

Solid Biosciences is a biotechnology company focused on developing innovative therapies for Duchenne muscular dystrophy (DMD). The company aims to address the underlying causes of DMD through its proprietary gene therapy platform. Solid Biosciences is committed to advancing the science of gene therapy and improving the lives of patients affected by this devastating disease. The company is engaged in various stages of clinical trials and collaborates with leading research institutions to enhance its therapeutic offerings.

Company facts

Industry
Biotechnology
Sub-industries
Gene Therapy, Pharmaceuticals, Clinical Research, Biopharmaceuticals, Regenerative Medicine
Location
Boston, United States
Employees
11–50
Revenue (USD)
1–5M
Founded
2013

Products and services

Open Solid Biosciences in GlobalDeal Is this your company? Update the details for free

More Biotechnology companies in United States

All 17,138 Biotechnology companies in United States →